Free Trial

Trading of Cumberland Pharmaceuticals was halted at 09:30 AM EST due to "LULD pause".

NASDAQ:CPIX

Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis

Cumberland Pharmaceuticals logo
$3.21 -0.58 (-15.30%)
Closing price 04:00 PM Eastern
Extended Trading
$3.22 +0.02 (+0.47%)
As of 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)

Key Stats

Today's Range
$2.95
$3.60
50-Day Range
$2.55
$5.89
52-Week Range
$1.04
$7.25
Volume
142,976 shs
Average Volume
706,677 shs
Market Capitalization
$48.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cumberland Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

CPIX MarketRank™: 

Cumberland Pharmaceuticals scored higher than 24% of companies evaluated by MarketBeat, and ranked 1738th out of 1,841 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Cumberland Pharmaceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cumberland Pharmaceuticals is -12.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cumberland Pharmaceuticals is -12.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cumberland Pharmaceuticals has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.08% of the float of Cumberland Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Cumberland Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cumberland Pharmaceuticals has recently decreased by 24.71%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cumberland Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Cumberland Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.08% of the float of Cumberland Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Cumberland Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cumberland Pharmaceuticals has recently decreased by 24.71%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cumberland Pharmaceuticals has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Cumberland Pharmaceuticals this week, compared to 9 articles on an average week.
  • Search Interest

    5 people have searched for CPIX on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cumberland Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    44.85% of the stock of Cumberland Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.51% of the stock of Cumberland Pharmaceuticals is held by institutions.

  • Read more about Cumberland Pharmaceuticals' insider trading history.
Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPIX Stock News Headlines

Trump’s SHOCKING Plan to Create MASSIVE Wealth for Americans
James Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presidential decision in modern history. According to his research, this could set off a massive wealth wave—potentially turning a $900 investment into $108,000 in under a year. It has nothing to do with tariffs or trade wars—but it’s already gaining momentum, and the window to act is closing fast.
See More Headlines

CPIX Stock Analysis - Frequently Asked Questions

Cumberland Pharmaceuticals' stock was trading at $2.37 at the beginning of the year. Since then, CPIX stock has increased by 35.4% and is now trading at $3.21.

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released its quarterly earnings results on Tuesday, August, 5th. The specialty pharmaceutical company reported $0.02 earnings per share (EPS) for the quarter. Cumberland Pharmaceuticals had a negative net margin of 7.98% and a positive trailing twelve-month return on equity of 6.92%.
Read the conference call transcript
.

Cumberland Pharmaceuticals' top institutional investors include Simplex Trading LLC. Insiders that own company stock include Kenneth Krogulski, James Jones and Caroline Young.
View institutional ownership trends
.

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cumberland Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Exxon Mobil (XOM), Netflix (NFLX) and Intel (INTC).

Company Calendar

Last Earnings
8/05/2025
Today
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:CPIX
CIK
1087294
Employees
80
Year Founded
1999

Profitability

EPS (Trailing Twelve Months)
($0.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.48 million
Net Margins
-7.98%
Pretax Margin
-8.08%
Return on Equity
6.92%
Return on Assets
2.33%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
1.25
Quick Ratio
1.09

Sales & Book Value

Annual Sales
$37.87 million
Price / Sales
1.29
Cash Flow
$0.21 per share
Price / Cash Flow
15.59
Book Value
$1.61 per share
Price / Book
2.03

Miscellaneous

Outstanding Shares
14,960,000
Free Float
8,251,000
Market Cap
$48.84 million
Optionable
Optionable
Beta
-0.39

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:CPIX) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners